Veterinary Medicines

Neopen Suspension for Injection

Authorised
  • NEOMYCIN SULFATE
  • Benzylpenicillin procaine
Download as PDF

Product identification

Medicine name:
Neopen Suspension for Injection
Active substance:
  • NEOMYCIN SULFATE
  • Benzylpenicillin procaine
Target species:
  • Cattle
  • Horse
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    115.96
    milligram(s)
    /
    1.00
    millilitre(s)
  • Benzylpenicillin procaine
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        29
        day
      • Milk
        3
        day
    • Horse
      • Meat and offal
        56
        day
    • Pig
      • Meat and offal
        39
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Ph.Eur. glass type II or PET bottle containing 100 ml, closed with butyl rubber stopper and sealed with aluminiumcap.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Productions S.r.l.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10996/006/002
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."